High efficacy of erlotinib in Taiwanese NSCLC patients in an expanded access program study previously treated with chemotherapy.
Perng RP, Yang CH, Chen YM, Chang GC, Lin MC, Hsieh RK, Chu NM, Lai RS, Su WC, Tsao CJ, Hsia TC, Chen HC, Chen CH, Huang MS, Wang JL, Ho ML, Chung CY, Yu CJ, Chang WC, Kuo HP, Yu CT, Lin ZZ, Kao WY.
Perng RP, et al. Among authors: kao wy.
Lung Cancer. 2008 Oct;62(1):78-84. doi: 10.1016/j.lungcan.2008.02.023. Epub 2008 Apr 18.
Lung Cancer. 2008.
PMID: 18423781
Clinical Trial.